5-fluorocytosine in the treatment of mycotic infections.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000963:Antimetabolites / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy; D001230:Aspergillus; D002176:Candida albicans; D002177:Candidiasis / Q000188:drug therapy; D002648:Child; D003453:Cryptococcosis / Q000188:drug therapy; D003596:Cytosine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005461:Fluorine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy*; D010676:Phialophora; D013175:Sporothrix
D000935:Antifungal Agents; D000963:Antimetabolites; D005461:Fluorine; D000666:Amphotericin B; D003596:Cytosine